Basal cell carcinoma

Miller S.J. Aetiology and pathogenesis of basal cell carcinoma. Clin Dermatol 1995; 13: 527–36.

Harvey I. , Frankel S. , Marks R. , Shalom D. , Nolan-Farrell M. Non-melanoma skin cancer and solar keratoses II: analytical results of the South Wales skin cancer study. Br J Cancer 1996; 74: 1308–12.

Harvey I. , Frankel S. , Marks R. , Shalom D. , Nolan-Farrell M. Non-melanoma skin cancer and solar keratoses. I. Methods and descriptive results of the South Wales skin cancer study. Br J Cancer 1996; 74: 1302–7.

Levi F. , la Vecchia C. , Te V.C. , Mezzanotte G. Descriptive epidemiology of skin cancer in the Swiss canton of Vauzd. Int J Cancer 1988; 42: 811–16.

Green A. Changing patterns in incidence of non-melanoma skin cancer. Epith Cell Biol 1992; 1: 47–51.

Marks R. , Jolley D. , Dorevitch A.P. , Selwood T. The incidence of non-melanocytic skin cancers in an Australian population: results of a five-year prospective study. Med J Amt 1989; 150: 475–8.

Kricker A. , Armstrong B.K. , English D.R. Sun exposure and non-melanocytic skin cancer. Cancer Causes Control 1994; 5(4): 367–92.

Marks R. , Jolley D. , Lectsas S. , Foley P. The role of childhood exposure to sunlight in the development of solar keratoses and non-melanocytic skin cancer. Med J Aust 1990; 152: 62–6.

Vitasa B.C. , Taylor H.R. , Strickland P.T. Association of nonmelanoma skin cancer and actinic keratosis with cumulative solar ultraviolet exposure in Maryland watermen. Cancer 1990; 65: 2811–17.

Gallagher R.P. , Hill G.B. , Bajdik C.D. Sunlight exposure, pigmentary factors, and risk of nonmelanocytic skin cancer. I. Basal cell carcinoma. Arch Dermatol 1995; 131(2): 157–63.

Marks R. Squamous cell carcinoma. Lancet 1996; 347: 735–8.

Yamada M. , Kodama K. , Fujita S. Prevalence of skin neoplasms among the atomic bomb survivors. Radiat Res 1996; 146: 223–6.

Gallagher R.P. , Bajdik C.D. , Fincham S. , Hill G.B. , Keefe A.R. , Coldman A. , McLean D.L. Chemical exposures, medical history and risk of squamous and basal cell carcinoma of the skin. Cancer Epidemiol Biomarkers Prev 1996; 5: 419–24.

Stern R.S. , Lange R. Non-melanoma skin cancer occurring in patients treated with PUVA five to ten years after first treatment. J Invest Dermatol 1988; 91: 120–4.

Strickland P.T. Photocarcinogenesis by near-ultraviolet (UVA) radiation in Sencar mice. J Invest Dermatol 1986; 87: 272–5.

Cleaver J.E. Xeroderma pigmentosum: a human disease in which an initial stage of DNA repair is defective. Proc Natl Acad Sci USA 1969; 63: 428–35.

Wei Q. , Mutanoski G.M. , Farmer E.R. , Hedayati M.A. , and Grossman L. DNA repair related to multiple skin cancers and drug use. Cancer Res 1994; 54: 437–40.

Lear J.T. , Heagerty A.H.M. , Smith A. Multiple cutaneous basal cell carcinomas: glutathione S-transferase (GSTM1, GSTT1) and cytochrome P450 (CYP2D6, CYP1A1) polymorphisms influence tumour numbers and accrual. Carcinogenesis 1996; 17: 1891–6.

Lear J.T. , Smith A.G. , Bowers B. Truncal tumour site is associated with high risk of multiple cutaneous basal cell carcinoma and is influenced by glutathione S-transferase, GSTT1 and cytochrome P450, CYP1A1 genotypes and their interactions. J Invest Dermatol 1997; 108: 519–22.

Lear J.T. , Heagerty A.H.M. , Smith A. , Bowers B. , Jones P.W. , Gilford J. Truncal site and detoxifying enzyme polymorphisms significantly reduce time to presentation of next cutaneous basal cell carcinoma. Carcinogenesis 1997; 18: 1499–503.

Streilein J.W. Sunlight and skin-associated lymphoid tissues (SALT): If UVB is the trigger and TNF-alpha is its mediator, what is the message? J Invest Dermatol 1993; 100: 47S–52S.

Gailani M.R. , Bale S.J. , Leffell D.J. Developmental defects in Gorlin's syndrome related to putative tumour suppressor gene on chromosome 9. Cell 1992; 69: 111–17.

Hahn H. , Wicking C. , Zaphiropoulos P.G. Mutations of the human homologue of drosophila patched in the naevoid basal cell carcinoma syndrome. Cell 1996; 85: 841–51.

Gailani M.R. , Stahle-Backdahl M. , Leffell D.J. The role of the human homologue of drosophila patched in sporadic basal cell carcinomas. Nature Genet 1996; 14: 78–81.

Karagas MR, for the Skin Cancer Prevention Study Group. Occurrence of cutaneous basal cell and squamous cell malignancies among those with a prior history of skin cancer. J Invest Dermatol 1994; 102: 10S–13S.

Lindelhof B. , Sigurgeirsson B. , Wallberg P. , Eklund G. Occurrence of other malignancies in 1973 patients with basal cell carcinoma. J Am Acad Dermatol 1991; 25: 245–8.

Frisch M. , Hjalgrim H. , Olsen J. , Melbye M. Risk for subsequent cancer after diagnosis of basal cell carcinoma. Ann Intern Med 1996; 125: 815–21.

Amonette R.A. , Salasche S.J. , Chesney T.M. , Clarendon C.C. Metastatic basal cell carcinoma. J Dermatol Surg Oncol 1981; 7: 397–400.

Lo J.S. , Snow S.N. , Reizner G.T. , Mohs F.E. , Larson P.O. , Hruza G.J. Metastatic basal cell carcinoma: report of twelve cases with a review of the literature. J Am Acad Dermatol 1991; 24: 715–19.

Motley R.J. , Gould D.J. , Douglas W.S. , Simpson N.B. Treatment of basal cell carcinoma by dermatologists in the United Kingdom. Br J Dermatol 1995; 132: 437–40.

Veien S.K. , Veien N.K. , Hattel T. , Laurberg G. Results of treatment of non-melanoma skin cancer in a dermatologic practice. A prospective study. Ugeskr Laeg 1996; 158: 7213–15.

Mak A.S. , Poon A.M. , Leung C.Y. Audit of basal cell carcinoma in Princess Margaret Hospital, Hong Kong: usefulness of frozen section examination in surgical treatment. Scand J Plast Reconstr Surg Hand Surg 1995; 29: 149–52.

Mallon E. , Dawber R. Cryosurgery in the treatment of basal cell carcinoma: assessment of one and two freeze—thaw cycles. Dermatol 1996; 22: 854–8.

Tuppurainen K. Cryotherapy for eyelid and periocular basal cell carcinomas: outcome in 166 cases over an 8 year period. Graefes Arch Clin Exp Ophthalmol 1995; 233: 205–8.

Salasche S.J. Status of curettage and desiccation in the treatment of primary basal cell carcinoma. J Am Acad Dermatol 1984; 10: 285–7.

Calzavara-Pinton P.G. Repetitive photodynamic therapy with topical delta-aminolaevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumours. J Photochem Photohiol B 1995; 29: 53–7.

Chimenti S. , Peris K. , Di Cristofaro S. Use of recombinant interferon alfa-2b in the treatment of basal cell carcinoma. Dermatology 1995; 190: 214–17.

Kopera D. , Cerroni L. , Fink-Puches R. , Kerl H. Different treatment modalities for the management of a patient with the naevoid basal cell carcinoma syndrome. J Am Acad Dermatol 1996; 34: 937–9.

Miller B.H. , Shavin J.S. , Cognetta A. Non-surgical treatment of basal cell carcinomas with intralesional 5-fluorouracil/epinephrine injectable gel. J Am Acad Dermatol 1997; 36: 72–7.

Stern R.S. , Weinstein M.C. , Bake S.G. Risk of non-melanoma skin cancer with childhood sunscreen use. Arch Dermatol 1986; 122: 537–45.

Naylor M.F. , Boyd A. , Cameron G.S. High sun protection factor sunscreens in the suppression of actinic neoplasia. Arch Dermatol 1995; 131: 170–5.

Jackson A. Prevention, early detection and team management of skin cancer: contribution to the Health of the Nation objectives. Br J Gen Pract 1995; 45: 97–101.

Rhodes A.R. Public education and cancer of the skin. What do people need to know about melanoma and non-melanoma skin cancer? Cancer 1995; 75(Suppl. 2): 613–36.

Lookingbill D.P. Yield from a complete skin examination: findings in 1157 new dermatology patients. J Am Acad Dermatol 1988; 18: 31–7.

Tangrea J.A. , Edwards B.K. , Taylor P.R. Long term therapy with low-dose isotretinoin for prevention of basal carcinoma: a multicentre clinical trial. Isotretinoin-basal cell carcinoma study group. J Natl Cancer Inst 1992; 84: 328–32.

Bavinck J.N. , Tieben L.M. , Van der Woude F.J. Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study. J Clin Oncol 1995; 13: 1933–8.

Greenberg E.R. , Baron J.A. , Stukel T.A. A clinical trial of beta carotene to prevent basal cell and squamous cell cancers of the skin. N Engl J Med 1990; 323: 789–95.